- Email: [email protected]
Primary radiation therapy for carcinoma of the breast
RadietionOncology~Biology0 Physics
1188
September 1981, Volume 7, Number 9
POSTGRADUATE EDUCATION PROGRAM, ASTR REFRESHER COURSES
Mondav, October 12. 1981 7:45 a.m. - 9:15 a.m. 100 - PRIMARY RADIATION THERAPY FOR CANCER OF THE BREAST Robert L. Goodman, M.D. 101 - CARCINOMA OF THE LARYNX James E. Marks, M.D. 102 - COMPLICATIONS IN THE TREATMENT OF GYNECOLOGIC CANCER Marvin Z. Rotrnan,M.D. 103 - HIGH LET RADIATION THERAPY - PIONS Steven E. Bush, M.D. 104 - PHYSICS OF ELECTRON BEAM THERAPY Peter R. Almond, Ph.D. 105 - PITUITARY TUMORS Barbara Danoff, M.D.
100 - PRIMARY RADIATION THERAPY FOR CARCINOMA OF THE BREAST Robert L. Goodman, M.D. Hospital of the University of Pennsylvania Philadelphia, Pennsylvania Sufficient data exist to support the use of irradiation as an alternative to mastectomy in clinical stages I and II carcinoma of the breast. These data will be reviewed briefly and referenced. More importantly, the technical factors associated with an excellent cosmetic outcome will be presented in detail including: the extent of the initial breast surgery, radiation fractionation and total dose, field arrangement, the use of compensators, and the avoidance of bolus. Less certain, but important other issues will be raised: the extent of axillary lymph node removal, the necessity of axillary irradiation with uninvolved lymph nodes, and whether or not boost irradiation is necessary, and, if so, whether implant or electrons are preferred. 101 - CARCINOMA OF THE LARYNX James E. Marks, M.D. Mallinckrodt Institute of Radiology St. Louis, Missouri The goals of this course will be to review for carcinomas of the larynx: 1) presentation and diagnostic workup, 2) normal anatomy and patterns of local and regional spread for glottic, supraglottic and transglottic lesions, 3) host and tumor factors that have progncstic significance, 4) radiation technique and dose response information for tumor and normal tissues, and 5) an overview of management by surgery and radiation including an analysis of primary tumor and nodal control, patterns of failure, voice preservation and post-treatment complications. Considerable attention will be devoted to comparing surgery and radiation alone or in combination for lesions of comparable location and size to find that treatment which gives maximum tumor control and voice preservation with least risk to the host.
1188
September 1981, Volume 7, Number 9
POSTGRADUATE EDUCATION PROGRAM, ASTR REFRESHER COURSES
Mondav, October 12. 1981 7:45 a.m. - 9:15 a.m. 100 - PRIMARY RADIATION THERAPY FOR CANCER OF THE BREAST Robert L. Goodman, M.D. 101 - CARCINOMA OF THE LARYNX James E. Marks, M.D. 102 - COMPLICATIONS IN THE TREATMENT OF GYNECOLOGIC CANCER Marvin Z. Rotrnan,M.D. 103 - HIGH LET RADIATION THERAPY - PIONS Steven E. Bush, M.D. 104 - PHYSICS OF ELECTRON BEAM THERAPY Peter R. Almond, Ph.D. 105 - PITUITARY TUMORS Barbara Danoff, M.D.
100 - PRIMARY RADIATION THERAPY FOR CARCINOMA OF THE BREAST Robert L. Goodman, M.D. Hospital of the University of Pennsylvania Philadelphia, Pennsylvania Sufficient data exist to support the use of irradiation as an alternative to mastectomy in clinical stages I and II carcinoma of the breast. These data will be reviewed briefly and referenced. More importantly, the technical factors associated with an excellent cosmetic outcome will be presented in detail including: the extent of the initial breast surgery, radiation fractionation and total dose, field arrangement, the use of compensators, and the avoidance of bolus. Less certain, but important other issues will be raised: the extent of axillary lymph node removal, the necessity of axillary irradiation with uninvolved lymph nodes, and whether or not boost irradiation is necessary, and, if so, whether implant or electrons are preferred. 101 - CARCINOMA OF THE LARYNX James E. Marks, M.D. Mallinckrodt Institute of Radiology St. Louis, Missouri The goals of this course will be to review for carcinomas of the larynx: 1) presentation and diagnostic workup, 2) normal anatomy and patterns of local and regional spread for glottic, supraglottic and transglottic lesions, 3) host and tumor factors that have progncstic significance, 4) radiation technique and dose response information for tumor and normal tissues, and 5) an overview of management by surgery and radiation including an analysis of primary tumor and nodal control, patterns of failure, voice preservation and post-treatment complications. Considerable attention will be devoted to comparing surgery and radiation alone or in combination for lesions of comparable location and size to find that treatment which gives maximum tumor control and voice preservation with least risk to the host.